Association gets ‘habeas corpus’ for cultivation of marijuana

by João Marcelo

SAU PAULO – The institution Cultive, a Cannabis Health association, which brings together patients who are treated with derivatives of marijuana from the city of São Paulo, has obtained a collective habeas corpus, which prevents its members from being arrested for growing the plant.

The measure is unprecedented, as this was the first request accepted by justice in the criminal sphere. The collective habeas corpus is a procedural instrument that aims to safeguard the rights of a certain group.

For judge Andrea Barrea, the entity seeks “the realization of the principle of dignity, as well as the rights to life and health, which must prevail over the prohibition on cultivating the plant from which the substance used for treatment is extracted of patients in a context of need, adequacy and proportionality ”, he wrote.

Before the favorable collective habeas corpus of the São Paulo justice system, other associations had already obtained legal permissions for the cultivation and use of cannabis for medicinal purposes, but all of them were handed down in the civil sphere.

Lawyer Erik Torquato, a member of the Reform (Legal Network for Drug Policy Reform), an association of lawyers responsible for most of the individual habeas corpus that have allowed the use of marijuana in medicinal treatments across the country, commented in an interview with Dire agency that “while in authorizations the judiciary is filling in a state omission to regulate an activity, in habeas corpus the judiciary is saying that the association’s conduct is not criminal. This has a much more significant symbolic value in relation to the distribution of marijuana between people”.

MARIJUANA USO MEDICO, GIUDICI DANNO RAGIONE A ‘CULTIVE’

di João Marcelo

SAN PAOLO DEL BRASILE – Non saranno arrestati per aver coltivato marijuana dopo aver ottenuto dai giudici un habeas corpus collettivo, i membri della istituzione Cultive, associazione Cannabis Saude, che a San Paolo riunisce i pazienti che usano prodotti derivati della cannabis per uso medico.

 » Continua a leggere su DIRE.IT…